Neurologist and author Daniel Gibbs, PhD, joins the podcast to discuss his recent book, “A Tattoo on My Brain,” which details his journey from treating Alzheimer’s disease clinically for 25 years to being diagnosed with early-stage Alzheimer’s. Dr. Gibbs discusses early signs he experienced and daily life with the disease, as well as thoughts on the recent FDA-approved treatment aducanumab (marketed as Aduhelm).
Guest: Daniel Gibbs, PhD, neurologist
Episode TopicsWhat inspired the title of your book, “A Tattoo on the Brain”? 1:01
What were these early signs of Alzheimer's disease that you recognized in yourself? 3:42
What were your impressions of the clinic process, and where is there room for improvement? 8:08
Can you share your view on family history? 9:17
What do you say to people about direct-to-consumer genetic testing, both as a recipient and as a clinician? 10:57
Did knowing your risk of Alzheimer's disease help or harm you? 12:42
Did you find any habit difficult to incorporate into your day? 13:17
How important was it for you to be involved in research and what did you gain from being a research participant? 17:15
How do you feel about the recent FDA approval of aducanumab for clinical use? 20:25
As a patient, would you sign up for this drug, and if you were still working as a neurologist, would you prescribe this drug? 22:59
How do you find the balance between enjoying daily life and engaging proactive activities meant to improve the future? 24:49
How can we reframe the way people understand Alzheimer's disease? 28:18
Was it difficult to publicly discuss your experience, and what have you learned from this process? 29:52
What do you hope the reader takes away from your book? 31:15
Find Dementia Matters online
Follow us on Facebook
Follow us on Twitter
Let’s Talk: Navigating Family Conversations about Dementia through Shared Decision-Making
Making an IMPACT: Advancing Alzheimer’s Disease Clinical Trials Through Workforce Development and Inclusivity
Living with Lewy Body: A Neurologist’s Journey Through Research and Dementia Care
The Fundamentals of Neuropsychology: Breaking Down Cognition, Memory and More
Long COVID and Its Effect on Cognition
Listen Up! The Connections Between Hearing Loss, Hearing Interventions and Cognitive Decline
From Caregiver to Research Participant: How One Woman’s Experience as a Dementia Caregiver Drew Her to Alzheimer’s Research
Looking at Lecanemab’s Eligibility Guidelines and Prescription Process
Do Non-Medicinal Interventions Reduce Dementia Risk? Studies are Inconclusive, Here’s Why
The Road to Hope: Philanthropy’s Impact on Alzheimer’s Research
Could Green Tea Hold the Key to New Alzheimer’s Treatments?
The Impact of Social Isolation on Dementia Risk in Older Adults
Memories and Milestones: Celebrating Six Years of ‘Dementia Matters’
Crosswords or Computers: Which is Better for Cognitive Engagement?
RAISE(ing) Support for Caregivers: State and National Resources for Family Care Partners
Mental Health and Memory: The Connections between Chronic Mental Illness and Dementia
Highlights from the 2023 Alzheimer’s Association International Conference
A Fair Fight Against Alzheimer’s: The Need for Equity in Dementia Research and Care
Agitation and Alzheimer’s: Strategies for Managing Behavioral and Psychological Symptoms of Dementia
Promises to Practice: Creating Sustainable Community Partnerships to Support Alzheimer’s Research
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Life in the A-Zone
Caregiver Storyteller - About Alzheimer’s and Dementia Caregiving
The Life, Love, and Alzheimer’s Podcast
Fading Memories: Alzheimer’s/Dementia Caregiver Support
Alzheimer’s Speaks